Seeking Alpha's  Instablog
Send Message is a meeting place for investors and public companies in leading sectors. Find investing ideas, news and research for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on... More
My company:
Investor Ideas
My blog:
Investor Ideas Newswire
  • Medical Technology Stock Trading Alert: Aethlon Medical (OTCQB: AEMD) Closes Up 12% On News Of Launch Of Exosome Science Subsidiary 0 comments
    Sep 13, 2013 11:52 AM | about stocks: AEMD

    Point Roberts, WA, New York, NY - September 13, 2013 ( newswire), an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a technical trading alert for Aethlon Medical, Inc. (OTCQB: AEMD). The stock closed trading on Thursday at $0.18, up $0.02 or 12.43% on volume of over 400,000 shares following news of a new Exosome Science subsidiary.

    The company on Thursday announced the formal launch of Exosome Sciences, Inc. (NYSE:ESI), a wholly-owned subsidiary previously established by Aethlon to pursue exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease and other life-threatening conditions. Exosomes produced by diseased cells represent an optimal diagnostic target as they are shed into bodily fluids such as urine and blood where they can be easily accessed. Exosomes transport specific disease-origin markers that provide the basis for ESI to establish non-invasive liquid biopsies to diagnose and monitor a wide-range of disease conditions. Newswire

    About Aethlon Medical (OTCQB: AEMD)

    Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under a 5-year contract with DARPA to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit

    About Big Ideas for global investors is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.

    Follow on Twitter!/Investorideas

    Follow on Facebook

    Follow News on at

    Sign up for free stock alerts

    Research more biotech and medical technology stocks:


    Themes: pharma, biotech Stocks: AEMD
Back To's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • Cachet Financial Solutions (OTCBB: $CAFN) Introduces Select Mobile(TM) Money to Money 20/20 2015 Audience
    Nov 10, 2015
  • $IDGS Included at Money2020: Growth for Mobile Payments Predicted/Security Concerns Potential Inhibitor
    Nov 9, 2015
  • Biometrics in Payment Industry: Gino Pereira, CEO of NXT-ID $NXTD about Wocket smart walllet at Money 20/20
    Nov 6, 2015
More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.